Published in AIDS Weekly, March 8th, 1999
"Treatment of tuberculosis in these (HIV positive) patients has been complicated by the introduction of highly active retroviral therapy (HAART), which relies on drugs that interfere with the most potent class of antituberculous medications," Neil W. Schluger noted in a recent commentary ("Issues in the Treatment of Active Tuberculosis in HIV Infected Patients," Clinical Infectious Disease, January 1999;28:130-135).
"Rifampin-free regimens or regimens that employ rifabutin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.